OTC · Medical - Devices

Getinge AB (publ) (GNGBY) Stock

$23.97 +0.23% OTC: GNGBY Healthcare

Getinge AB (publ) is a prominent global medical technology provider, delivering comprehensive products and solutions primarily to operating rooms, intensive care units, and sterilization departments. The company operates through three distinct segments: Acute Care Therapies, Life Science, and Surgical Workflows.

Valuation

MetricValue
Price$23.97
Market Cap$6.53B
P/E Ratio23.72
P/B Ratio2.05
P/S Ratio1.86
EPS (TTM)$1.01
52-Week High$24.67
52-Week Low$18.99
Dividend Yield2.13%

Financials & Margins

MetricValue
ROE8.88%
ROA4.66%
ROCE10.24%
Gross Margin47.57%
Operating Margin13.56%
Net Margin7.82%
Debt/Equity0.36
Current Ratio1.31

Annual Financials (USD)

Metric20212022202320242025
Revenue$27.0B$28.3B$31.8B$34.8B$35.0B
Operating Profit$4.4B$3.6B$3.7B$2.9B$3.8B
Net Profit$3.0B$2.5B$2.4B$1.6B$2.3B
EPS$10.90$9.15$8.86$6.01$8.29
Op Margin16.2%12.8%11.7%8.2%10.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$44.6B$52.0B$53.5B$63.9B$56.5B
Total Liabilities$19.4B$21.6B$23.2B$30.7B$27.0B
Cash$4.1B$5.7B$2.7B$3.0B$3.4B
Borrowings$4.3B$5.8B$8.1B$10.7B$10.9B

Latest News

MTD Second Quarter Earnings Beat Estimates on China-Led Sales Growth Zacks · Aug 3, 2026 Getinge Interim Report April-June 2026: Good organic growth, high profitability and strong cash flow PR Newswire · Jul 17, 2026 Global Medical Ventilators Market Report 2025-2030 Just Released; Comprehensive Profiles of Getinge, Drägerwerk, Philips, Medtronic, and ResMed GlobeNewswire · Jul 9, 2026 Brenus Pharma Strengthens Its Governance With Designation of a New President and Appointment of Former Novo Nordisk EVP as Independent Member Business Wire · Jul 2, 2026 [Latest] Global Neonatal Intensive Care Respiratory Devices Market Size/Share Worth USD 5.7 Billion by 2035 at a 10.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis) GlobeNewswire · Jun 24, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$6.6B$3.4B$3.0B$4.6B$3.9B
Investing Cash Flow$-2.3B$-2.6B$-7.9B$-5.9B$-4.3B
Financing Cash Flow$-390.0M$-410.0M$-52.0M$-476.0M$-498.0M
Net Cash Flow$-2.0B$1.6B$-2.9B$232.0M$440.0M
Free Cash Flow$5.6B$2.2B$1.6B$3.3B$2.6B

Valuation & Return Ratios

MetricValue
PEG Ratio0.30
EV / EBITDA11.24
FCF Yield5.99%
Quick Ratio0.74
Interest Coverage7.80
Return 1Y23.61%
Return 3Y39.57%
Return 5Y-35.94%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Getinge AB (publ)

Getinge AB (publ) is a prominent global medical technology provider, delivering comprehensive products and solutions primarily to operating rooms, intensive care units, and sterilization departments. The company operates through three distinct segments: Acute Care Therapies, Life Science, and Surgical Workflows. Its extensive product portfolio for sterile environments includes advanced transfer systems, closure processing systems, washers, isolators, sterilizers, and automated logistic solutions. For the life sciences sector, Getinge offers bioreactors, bioprocess control systems, software, biobundles, analytics, and perfusion systems. Within acute care and surgical settings, offerings span anesthesia machines, patient monitoring systems and disposables, and specialized cardiac surgery tools like beating heart stabilizers and coronary shunts. This segment also provides ceiling supply units, integrated digital solutions, and various cleaning, disinfection, packaging, and sealing products, including its SteriTec range. Further extending its medical device offerings, Getinge supplies a wide array of specialized items such as thoracic catheters, diverse chest drain systems, and related accessories. The portfolio also covers endoscope reprocessing, endoscopic vessel harvesting, endovascular products, and critical extracorporeal life support (ECMO) and intra-aortic balloon pump therapies. Additional provisions include mechanical ventilation, medical furniture, modular room systems, state-of-the-art operating lights and tables, comprehensive OR integration and management solutions, patient flow management systems, and solutions for patient transport, sterile supply management, surgical assist, and surgical perfusion, alongside vascular and cardiothoracic surgery solutions. Getinge distributes its products and solutions globally through a robust network that includes proprietary sales companies, agents, and distributors. This network spans the Americas, Europe, the Middle East, Africa, and the Asia Pacific regions. Founded in 1904, Getinge AB (publ) maintains its corporate headquarters in Gothenburg, Sweden.

Getinge AB (publ) is headquartered in SE.

Getinge AB (publ) (GNGBY) stock trades at $23.97 with a market capitalization of $6.53B. The stock is valued at a price-to-earnings (P/E) ratio of 23.72, price-to-book of 2.05, price-to-sales of 1.86. Over the past 52 weeks the stock has ranged between $18.99 and $24.67, and currently trades 2.8% below its 52-week high. It pays a dividend yielding 2.13%.

On profitability, Getinge AB (publ) generates a return on equity (ROE) of 8.88%, return on capital employed of 10.24%, an operating margin of 13.56%, a net profit margin of 7.82%.

Official website: www.getinge.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides